Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 1 May 23 EFFECT Notice of effectiveness
- 28 Apr 23 424B3 Prospectus supplement
- 26 Apr 23 S-4/A Registration of securities issued in business combination transactions (amended)
- 21 Apr 23 S-4/A Registration of securities issued in business combination transactions (amended)
- 13 Apr 23 S-4/A Registration of securities issued in business combination transactions (amended)
- 29 Mar 23 S-4/A Registration of securities issued in business combination transactions (amended)
-
13 Feb 23 S-4 Registration of securities issued in business combination transactions
ELTX similar filings
- 21 Apr 23 Registration of securities issued in business combination transactions (amended)
- 13 Apr 23 Registration of securities issued in business combination transactions (amended)
- 29 Mar 23 Registration of securities issued in business combination transactions (amended)
- 13 Feb 23 Registration of securities issued in business combination transactions
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the use in this Registration Statement on Form S-4 of Angion Biomedica Corp. of our report dated March 30, 2022, relating to the consolidated financial statements of Angion Biomedica Corp. (the “Company”). We also consent to the reference to us under the heading “Experts” in such Registration Statement.
/s/ Moss Adams LLP
Seattle, WA
February 13, 2023